Synthesis and biological evaluation of technetium-sarafloxacin complex for infection imaging

Journal of Radioanalytical and Nuclear Chemistry

Volumn 307, Issue 1, 2016, Pages 699-705

  Moustapha, M E ^a   Motaleb, M A ^b   Shweeta, H ^b,c   Farouk, Mahmoud ^a,d  

^a PRINCE SATTAM BIN ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b Atomic Energy Authority   (Egypt)

^c UMM AL QURA UNIVERSITY   (Saudi Arabia)

^d NEW VALLEY UNIVERSITY   (Egypt)

Author keywords

Diagnosis; Infection; Inflammation; Labeling; Sarafloxacin

Indexed keywords

CIPROFLOXACIN; CIPROFLOXACIN TC 99M; NORDIFLOXACIN; SARAFLOXACIN TC 99M; TECHNETIUM 99M; TIN CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BIOLOGICAL ACTIVITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; IN VITRO STUDY; IN VIVO STUDY; INFECTION IMAGING; INFLAMMATION; ISOTOPE LABELING; MOUSE; NONHUMAN; PH; REACTION TIME;

EID: 84953367767     PISSN: 02365731     EISSN: 15882780     Source Type: Journal    
DOI: 10.1007/s10967-015-4188-0     Document Type: Article

References (41)

1. Otto CB, Huub R, Wim JG, Corstens FM (2001) Semin Nucl Med 31:288–295
2. Gemmel F, Dumarey N, Welling M (2009) Semin Nucl Med 39:11–26
3. Lucignani G (2007) Eur J Nucl Med Mol Imaging 34:1873–1877
4. Langer O, Brunner M, Zeitlinger M, Ziegler S, Müller U, Dobrozemsky G (2005) Eur J Nucl Med Mol Imaging 32:143–150
5. Saha GB (2004) The fundamentals of nuclear pharmacy, 5th edn. Springer, New York
6. Lupetti A, Welling MM, Pauwels EK, Nibbering PH (2007) Lancet Infect Dis 3:223–239
7. Yapar AF, Togrul E, Kayaselcuk U (2001) Eur J Nucl Med 28:822–830
8. Palestro CJ (2007) J Nucl Med 48:332–334
9. Moustapha ME, Motaleb MA, Ibrahim IT (2011) J Radioanal Nucl Chem 287:35–40
10. Singh AK, Verma J, Bhatnagar A, Ali A (2003) World J Nucl Med 2:103–109
11. Sakr TM, Moustapha ME, Motaleb MA (2013) J Radioanal Nucl Chem 295:1511–1516
12. Martin-Comin J, Soroa V, Rabiller G, Galli R, Cuesta L, Roca M (2004) Rev Esp Med Nucl 23:357–358
13. Brunton LL, Parker KL (2008) Goodman & Gilman’s manual of pharmacology and therapeutics. McGraw-Hill, New York
14. Singh B, Babbar AK, Sarika S, Kaul A, Bhattacharya A, Mittal BR (2010) J Nucl Med 51(Suppl 2):373
15. Asikoglu M, Yurt F, Cagliyan O, Unak P, Ozkilic H (2000) Appl Rad Isot 53:411–413
16. Motaleb MA, El-Kolaly MT, Ibrahim AB, El-Bar AA (2011) J Radioanal Nucl Chem 289:57–65
17. Ibrahim IT, Motaleb MA, Attalah KM (2010) J Radioanal Nucl Chem 285:431–436
18. Motaleb MA (2010) J Label Compd Radiopharm 53:104–109
19. Motaleb MA (2009) J Label Compd Radiopharm 52:415–418
20. Motaleb MA (2007) J Radioanal Nucl Chem 272:95–99
21. Siaens RH, Rennen HJ, Boerman OC, Dierckx R, Slegers G (2004) Nucl Med 45:2088–2094
22. Anderson DC, Kodukula K (2014) Bioch Pharm 87:172–188
23. Dumarey N, Blocklet D, Appelboom T, Tant L, Schoutens A (2002) Eur J Nucl Med 29:530–535
24. Chattopadhyay S, Das SS, Chandra S, De K, Mishra M, Sarkar BR, Sinha S, Ganguly S (2010) Appl Rad Isot 68:314–316
25. Gemmel F, Winter F, DeVanLaere K, Vogelaers D, Uyttendaele D, Dierckx RA (2004) Nucl Med Comm 25:277–283
26. Sarda L, Cre´mieux A, Lebellec Y, Meulemans A, Lebtahi R, Hayem G (2003) J Nucl Med 44:920–926
27. Siaens RH, Rennen HJ, Boerman OC, Dierckx R, Slegers G (2004) J Nucl Med 45:2088–2094
28. Sarda L, Saleh-Mghir A, Peker C, Meulemans A, Cre´mieux AC, Guludec LD (2002) J Nucl Med 43:239–245
29. Pauwels EK, Welling MM, Lupetti A, Nibbering PH (2001) Eur J Nucl Med 28:779–781
30. Larikka MJ, Ahonen AK, Niemelä O, Junila JA, Hämäläinen MM, Britton K (2002) Nucl Med Commun 23:167–170
31. Signore AD, Alessandria C, Lazzeri E, Dierck R (2008) Eur J Nucl Med Mol Imaging 35:1051–1055
32. Britton KE, Vinjamuri S, Hall AV, Solanki K, Siraj QH, Bomanji J (1997) Eur J Nucl Med 24:553–556
33. Zolle I (2007) Technetium-99 m radiopharmaceuticals: preparation and quality control in nuclear medicine. Springer, Berlin
34. Piervincenzi Ronald T (2008) United states pharmacopeia/national formulary (USP/NF). USP, Rockville
35. Moustapha ME, Motaleb MA, Ibrahim IT, Moustafa ME (2013) Radiochem 55:116–122
36. Moustapha ME, Shweeta H, Motaleb MA (2014) ARABJC. doi:10.1016/j.arabjc.2014.10.017
37. Larikka MJ, Ahonen AK, Niemelä O, Junila JA, Hämäläinen MM, Britton K (2002) Nucl Med Commun 23:655–661
38. Oyen WJG, Boerman OC, Corstens FHM (2001) J Microbiol Meth 47:151–157
39. Kaul A, Hazari PP, Rawat H, Singh B, Kalawat TC, Sharma S, Anil Babbar AK, Mishra AK (2013) Int J Infect Dis 17:263–270
40. Jurisson SS, Lydon JD (1999) Chem Rev 99:2205–2218
41. Rien HS, Huub JR, Otto CB, Rudi D, Guido S (2004) J Nucl Med 45:2088–2094